1. Home
  2. MLEC vs PRFX Comparison

MLEC vs PRFX Comparison

Compare MLEC & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moolec Science SA

MLEC

Moolec Science SA

HOLD

Current Price

$6.48

Market Cap

2.6M

Sector

Finance

ML Signal

HOLD

Logo PainReform Ltd.

PRFX

PainReform Ltd.

HOLD

Current Price

$0.95

Market Cap

2.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLEC
PRFX
Founded
2008
2007
Country
Cayman Islands
Israel
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6M
2.7M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
MLEC
PRFX
Price
$6.48
$0.95
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
608.9K
3.6M
Earning Date
02-03-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$20.42
N/A
Revenue Next Year
$30.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
170.36
N/A
52 Week Low
$3.08
$0.61
52 Week High
$120.00
$6.65

Technical Indicators

Market Signals
Indicator
MLEC
PRFX
Relative Strength Index (RSI) 64.21 55.33
Support Level $4.18 $0.85
Resistance Level $12.96 $1.59
Average True Range (ATR) 1.54 0.12
MACD 0.26 0.03
Stochastic Oscillator 46.59 32.66

Price Performance

Historical Comparison
MLEC
PRFX

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.

About PRFX PainReform Ltd.

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

Share on Social Networks: